The maximum retail price (MRP) of medications and formulations that are no longer subject to customs duty has been adjusted by the National Pharmaceutical Pricing Authority (NPPA) in accordance with this year's budget.
Aurobindo Pharma has announced that the European Commission (EC) has granted marketing authorization in the European Union (EU) for Zefylti, a filgrastim biosimilar, to CuraTeQ Biologics s.r.o., a wholly owned step-down subsidiary of the Company....
In the context of ongoing US-India discussions on tariffs, key pharmaceutical industry bodies in India—Pharmaceuticals Exports Promotion Council (Pharmexcil), Indian Pharmaceutical Association (IPA), and Indian Drug Manufacturers Association (IDMA...
Indian companies in the pharmaceutical and steel sectors remain largely unaffected by the Trump administration’s impending trade tariffs, with industry leaders downplaying concerns about their impact on Indian exports to the US.
Aurobindo Pharma will commence supplies to Europe from its China facility from April onwards, according to Chief Financial Officer Santhanam Subramanian. The Hyderabad-based drug maker commenced operations at the facility in the last week of Novem...
Global private equity giant KKR is set to acquire a controlling 51% stake in Healthcare Global Enterprises (HCG), a leading Bengaluru-based cancer care hospital chain, from CVC Capital Partners, according to sources familiar with the deal. This mo...
Hundreds of millions of dollars' worth of life-saving medical supplies are stranded in warehouses and on ships worldwide due to former U.S. President Donald Trump's decision to freeze foreign aid, sources familiar with the humanitarian program tol...
The government has granted a one-year extension to small and medium-sized pharmaceutical companies (with annual turnover below Rs 250 crore) to meet the revised Schedule M standards, which set quality standards and good manufacturing practices (GM...
AstraZeneca Pharma India is set to sell its 64-acre production facility in North Bengaluru as part of a strategic review of its global manufacturing and supply network by its parent company. The deal is expected to generate over ?3,200 crore and a...
Sanofi Healthcare India has received marketing authorization for Rezurock (belumosudil tablets) in India for the treatment of chronic Graft-versus-host disease (cGVHD) in patients aged 12 years and above.Rezurock is used globally for cGVHD pati...
, CDSCO.jpg)
